|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/00 |
| (11) | Number of the document | 2675893 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12747134.0 |
| Date of filing the European patent application | 2012-02-17 | |
| (97) | Date of publication of the European application | 2013-12-25 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/025712 |
| Date | 2012-02-17 |
| (87) | Number | WO 2012/112933 |
| Date | 2012-08-23 |
| (30) | Number | Date | Country code |
| 201161444666 P | 2011-02-18 | US |
| (72) |
SCHULTZ, Peter, US
LAIRSON, Luke, US
DESHMUKH, Vishal, US
LYSSIOTIS, Costas, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
The Scripps Research Institute, Mail Drop TPC-8 10550 North Torrey Pines Road, La Jolla, CA 92037, US |
| (54) | DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE |
| DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE |